Rx (Prescription Medicine)
Twinaqt Dolutegravir Lamivudine Tablets are manufactured by Emcure Pharmaceuticals Ltd. in India and contain 50 mg Dolutegravir and 300 mg of Lamivudine per tablet. Each Bottle pack includes 30 tablets in 1 bottle, making Twinaqt Dolutegravir Lamivudine Tablets a practical option for HIV. A prescription is required from your healthcare provider to purchase Dolutegravir Lamivudine medicine. Indogenmed deals in all types of generic Dolutegravir Lamivudine medicine.
| Brand Name | |
|---|---|
| Pack Quantity | 30 Tablets |
| Country Of Origin | India |
| Medicine Form | Tablet |
| Medicine Type | Generic |
| Molecule | |
| Packaging Type | Bottle |
| Packaging Type | Bottle |
| Rx Status | Rx (Prescription Medicine) |
| Rx Status | Rx (Prescription Medicine) |
| Strength | 100 Mg, 50 Mg |
Only logged in customers who have purchased this product may leave a review.
Price range: USD $ 99.00 through USD $ 295.00
Price range: USD $ 109.00 through USD $ 315.00
Price range: USD $ 125.00 through USD $ 366.00
Price range: USD $ 40.00 through USD $ 111.00
Price range: USD $ 195.00 through USD $ 679.00
Price range: USD $ 320.00 through USD $ 945.00
Other brands of Dolutegravir, Lamivudine 100 Mg — the same active ingredient at the same strength, from a different manufacturer.
Exact match
Viropil Tablets
Original price was: USD $ 110.00.USD $ 90.00Current price is: USD $ 90.00.
USD $ 3.00 per unit
Exact match
Spegra Tablets
Price range: USD $ 24.00 through USD $ 69.00
USD $ 0.80 per unit
Same molecule
Viraday 600 Mg Tablets
Original price was: USD $ 136.45.USD $ 109.16Current price is: USD $ 109.16.
USD $ 10.92 per unit
Same molecule
Vonaday Tablets
USD $ 110.00
USD $ 3.67 per unit
Medically reviewed by
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
Reviews
There are no reviews yet.